Vimarsana
Biggest News Aggregation in the World

Page 2 - Wellbeing Digital Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wellbeing Digital Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wellbeing Digital Sciences Today - Breaking & Trending Today

Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference - Vimarsana News

Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference

Wellbeing Digital Sciences Inc. , an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... | May 25, 2023

Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response - Vimarsana News

Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response

A randomized, triple-blind, placebo-controlled clinical trial involving supplementation with UP360 provides evidence for a robust, healthy immune response in healthy adults following influenza... | May 3, 2023

Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial - Vimarsana News

Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial

Wellbeing Digital Sciences Inc. , an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... | April 18, 2023

Nova Mentis Life Science Corp.: Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial - Vimarsana News

Nova Mentis Life Science Corp.: Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial

Vancouver, British Columbia--(Newsfile Corp. - April 18, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader

Nova Mentis Life Science Corp.: Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial - Vimarsana News

Nova Mentis Life Science Corp.: Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial

Vancouver, British Columbia--(Newsfile Corp. - April 11, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader